iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Cumberland Advisors Inc.

Cumberland Advisors Inc. cut its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 3.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 74,073 shares of the financial services provider’s stock after selling 2,880 shares during the quarter. iShares Biotechnology ETF comprises approximately 3.9% of Cumberland Advisors Inc.’s portfolio, making the stock its 7th biggest holding. Cumberland Advisors Inc.’s holdings in iShares Biotechnology ETF were worth $9,793,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the stock. Williams Financial LLC purchased a new position in shares of iShares Biotechnology ETF in the 2nd quarter worth about $867,000. PVG Asset Management Corp purchased a new position in iShares Biotechnology ETF in the second quarter valued at approximately $415,000. Huntington National Bank lifted its position in iShares Biotechnology ETF by 17.9% during the third quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock valued at $153,000 after buying an additional 160 shares in the last quarter. National Bank of Canada FI grew its stake in iShares Biotechnology ETF by 5.9% during the third quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock worth $600,000 after buying an additional 229 shares during the period. Finally, First Financial Bank Trust Division acquired a new stake in shares of iShares Biotechnology ETF in the third quarter worth $204,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB traded down $0.64 during midday trading on Wednesday, hitting $134.83. 1,339,853 shares of the company’s stock traded hands, compared to its average volume of 1,185,399. The firm’s fifty day moving average price is $138.42 and its two-hundred day moving average price is $142.10. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.